Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (NZ337696) Improvements in or relating to long-acting antimicrobials

Office : New Zealand
Application Number: 337696 Application Date: 06.05.1997
Publication Number: 337696 Publication Date: 23.02.2001
Grant Number: Grant Date: 06.06.2001
Publication Kind : B
Prior PCT appl.: Application Number:PCTGB1997001222 ; Publication Number: Click to see the data
IPC:
A61K 31/455
A61K 31/65
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
455
Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
65
Tetracyclines
Applicants: NORBROOK LABORATORIES LIMITED
Inventors: Patterson, Alan
Orr, Neil
Agents: AJ PARK
Priority Data:
Title: (EN) Improvements in or relating to long-acting antimicrobials
Abstract:
(EN) Patent 337696 The specification describes a veterinary product comprising an antimicrobial selected from the group consisting of tetracyclines such as oxytetracycline, cephalosporins, penicillins such as ampicillin, amoxycillin, penicillin G or the like, macrolides such as erythromycin, tylosin, tilmicosin or the like or aminoglycosides such as dihydrostreptomycin or the like or a quinolone or the like, or a sulphonamide or a diaminopyrimidine eg, trimethoprim or the like, with a predetermined amount of an anti-inflammatory agent. The anti-inflammatory agent is selected from the group consisting of indolines such as indomethacin, salicylates such as aspirin, oxicams such as piroxicam, acetic acid such as diclofenac, fenamates such as tolfenamic acid, propionic acids such as ketoprofen, para amino phenol derivatives such as acetaminophen, pyrazoles such as phenylbutazone, sulphonanilides such as nimesulide, or other drugs possessing anti-inflammatory or anti-pyretic capabilities. Preferably, the veterinary product contains 300mg/ml oxytetracycline, 20mg/ml flunixin and a physiologically acceptable vehicle or carrier...
Also published as:
NO19994787SK124099TR1999/02748IL132676EP0980248KE1997000109
US6479473CA2285052DE000069707927AU1997027061DK0980248WO/1998/050045